China Medical System Holdings Limited
CHSYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7 | $8 | $9 | $8 |
| % Growth | -6.8% | -12.4% | 9.8% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $5 | $6 | $7 | $6 |
| % Margin | 72.6% | 75.8% | 76.9% | 74.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $3 | $3 | $3 | $3 |
| Other Operating Expenses | -$0 | $0 | -$0 | -$0 |
| Operating Expenses | $4 | $3 | $3 | $3 |
| Operating Income | $2 | $3 | $4 | $3 |
| % Margin | 23.2% | 33.9% | 38.8% | 37.8% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $2 | $3 | $4 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2 | $2 | $3 | $3 |
| % Margin | 21.7% | 30% | 35.6% | 36.2% |
| EPS | 0.67 | 0.98 | 1.33 | 1.22 |
| % Growth | -31.6% | -26.3% | 9% | – |
| EPS Diluted | 0.67 | 0.98 | 1.33 | 1.22 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $3 | $4 | $4 |
| % Margin | 30.9% | 36.5% | 41.1% | 44.4% |